Nanobiotix S.A. (0QAV.L) LSE
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 925.79M |
| Enterprise Value | 968.36M |
| P/E Ratio | -26.44 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 173.15 |
| Price/Book Ratio | -42.58 |
| Enterprise/Revenue | 172.65 |
| Enterprise/EBITDA | -45.3 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -6.18 |
| Operating Margin | -3.68 |
AD
Management Effectiveness
| Return On Assets | -0.41 |
| Return On Equity | 0.9 |
Income Statement
| Revenue | 29.64M |
| Revenue/Share | 0.18 |
| Gross Profit | 0 |
| EBITDA | -12.22M |
| Net Income | -23.96M |
| Diluted EPS | -0.5 |
Balance Sheet
| Total Cash | 110.89M |
| Total Cash/Share | 2.27 |
| Total Debt | 106.61M |
| Total Debt/Equity | -3.19 |
| Current Ratio | 1.44 |
| Book Value Per Share | -0.68 |
Price History
| 52-Week Change | 56.89 |
| 52-Week High | 47.6 |
| 52-Week Low | 16.52 |
| Moving Average 50 Days | 27.08 |
| Moving Average 200 Days | 29.57 |
Statistics
| Average Volume | 20,297 |
| Shares Outstanding | 50.95M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
